01931 IVD MEDICAL
- 2.230
- -0.040-1.76%
IVD MEDICAL News
華檢醫療：變更股東週年大會日期、記錄日期、暫停登記期及股息派付日期
IVD Medical Holding Limited's (HKG:1931) Top Holders Are Insiders and They Are Likely Disappointed by the Recent 11% Drop
Key Insights IVD Medical Holding's significant insider ownership suggests inherent interests in company's expansion 59% of the business is held by the top 3 shareholders Using data from company's
IVD MEDICAL: Annual Report 2023
Investor Optimism Abounds IVD Medical Holding Limited (HKG:1931) But Growth Is Lacking
With a price-to-earnings (or "P/E") ratio of 11.8x IVD Medical Holding Limited (HKG:1931) may be sending bearish signals at the moment, given that almost half of all companies in Hong Kong have P/E ra
IVD MEDICAL To Go Ex-Dividend On May 20th, 2024 With 0.06209 HKD Dividend Per Share
March 16th - $IVD MEDICAL(01931.HK)$ is trading ex-dividend on May 20th, 2024. Shareholders of record on May 21st, 2024 will receive 0.06209 HKD dividend per share on May 29th, 2024. The ex-divide
Gelonghui Announcements Selected (Hong Kong Stocks) | Fuyao Glass (03606.HK) Announces Annual Results: Net Profit Increased by 18.37% to RMB 5.629 billion, with an estimated capital requirement of RMB 41,016 billion for the full year of 2024
[Today's Focus] Fuyao Glass (03606.HK) announced annual results: net profit increased by 18.37% to 5.629 billion yuan, with an estimated capital requirement of 41,016 billion yuan for 2024 Fuyao Glass (03606.HK) announced annual results. For the year ended December 31, 2023, the company consolidated revenue of RMB 33.161 billion, an increase of 18.02% over the same period of the previous year; achieved profit before tax of RMB 6.715 billion, an increase of 20.38% over the same period of the previous year, and achieved an annual profit of RMB 20.38% over the same period last year 5.629 billion yuan, compared to the previous year
Huajian Healthcare (01931) will pay a final dividend of HK$0.06209 per share on May 29
Huajian Medical (01931) issued an announcement that it will be distributed on May 29, 2024 until December 3, 2023...
Profit attributable to owners of Huajian Healthcare (01931.HK)'s 2023 parent company increased 13.4% year-on-year
Gelonghui, March 15, 丨 Huajian Medical (01931.HK) announced that for the year ended December 31, 2023, the Group recorded revenue of RMB 3,089 billion, an increase of 12.4% over the same period in 2022. Profit attributable to owners of parent companies was RMB 238 million, an increase of 13.4% over the same period in 2022. The increase in revenue is mainly due to increased demand for IVD products from end customers, which is due to the gradual return of hospital operations to normal after COVID-19. The increase in profit during the year was mainly due to (i) increased earnings; and (ii) share award schemes
IVD MEDICAL: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Huajian Healthcare (01931): Liu Fei appointed as non-executive director
Huajian Healthcare (01931) issued an announcement. Yang Zhaoxu resigned as a non-executive director due to his retirement, and Liu Fei was appointed as a non-executive director...
Huajian Healthcare (01931.HK) will hold a board meeting on March 15 to approve the annual results
Gelonghui March 5 | Huajian Healthcare (01931.HK) announced that the company will hold a board meeting on March 15, 2024 to consider and approve the Group's annual results for the year ended December 31, 2023, pay a final dividend (if any), and handle any other matters.
IVD Medical Holding (HKG:1931) Might Have The Makings Of A Multi-Bagger
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) an
Huajian Healthcare (01931) rose 10.90% and now reports 2.140 yuan, a 52-week high
As of 11:59 p.m., Huajian Healthcare (01931) is 10.90% higher than yesterday's closing price and is now reporting a 52-week high of $2.140; the trading volume is 98,000 shares, with a turnover of HK$191,800.
Huajian Healthcare (01931.HK): Sun Tao resigns as non-executive director
Gelonghui January 31 | Huajian Medical (01931.HK) announced that the company has received Sun Tao's proposal to resign as a non-executive director due to his work adjustments, effective January 30, 2024.
The strategic cooperation agreement signed between Huajian Medical (01931.HK) and Heeson Meikang Shanghai on a strategic cooperation in the blood coagulation products business has been completed
Gelonghui, December 28, 丨 Huajian Healthcare (01931.HK) announced that on December 28, 2023, the strategic cooperation agreement signed between Weishida, a wholly-owned subsidiary of the company, and Heathson Meikang Shanghai on strategic cooperation in the blood coagulation products business has been completed. The strategic cooperation will strengthen the relationship between the two parties. Under normal circumstances, it is possible to effectively maintain the supply of Heathson Macron products distributed by Wisdom and maintain the regions where Westar is authorized to distribute. The strategic cooperation will also enable the two sides to utilize their respective strengths, resources and expertise to continue to develop a long-term and mutually beneficial strategic relationship with the Group.
IVD Medical Unit Hired as Distributor by Controlling Shareholder for One Year
IVD Medical Holding (HKG:1931) unit Vastec Medical Equipment (Shanghai) has agreed to act as a distributor for certain products of controlling shareholder Shinva Medical Instrument in Mainland China f
Sysmex Unit Plans to Acquire Shares in IVD Medical's Subsidiary
Sysmex's (TYO:6869) unit, Sysmex Shanghai, plans to inject capital to and become a shareholder of IVD Medical Holding's (HKG:1931) subsidiary, Vastec Medical Equipment (Shanghai), as part of a coopera
Huajian Medical and Heeson Meikang signed a strategic cooperation agreement for the coagulation products business of both parties
Huajian Medical (01931) announced that on November 2, 2023, Weishida Medical Equipment (Shanghai) Co., Ltd., a wholly-owned subsidiary of the company, and Heeson Meikang Medical Electronics (Shanghai) Co., Ltd. signed a number of agreements for strategic cooperation in the coagulation product business between the two sides. Considering the history of cooperation over the past 26 years, in order to better cope with future market changes, Wisda and Heeson Meikang Shanghai agreed that the two sides should deepen cooperation and sign a strategic cooperation agreement for this purpose. The main contents include (subject to a number of regular prerequisites) the two parties revising Wisda's existing distribution rights and Weishida's equity structure
IVD Medical Holding Limited (HKG:1931) Adds HK$515m in Market Cap and Insiders Have a 44% Stake in That Gain
Key Insights IVD Medical Holding's significant insider ownership suggests inherent interests in company's expansion 59% of the business is held by the top 3 shareholders Past performance of a com
IVD MEDICAL: Interim Report 2023
Analysis
Price Target
No Data
